All News Tectonic Therapeutic, Inc.

Equities

AVRO

US8789721086

Market Closed - Nasdaq Other stock markets 01:30:00 27/06/2024 am IST			5-day change	1st Jan Change
15.93 ^USD	-0.25%		-6.51%	-2.39%

20/06	Avrobio Closes Merger With Tectonic Therapeutic	MT
20/06	Tectonic Therapeutic, Inc. announced that it has received $96.599856 million in funding from Tas Partners, LLC	CI

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Avrobio Closes Merger With Tectonic Therapeutic	21/06	MT
Tectonic Therapeutic, Inc. announced that it has received $96.599856 million in funding from Tas Partners, LLC	20/06	CI
AVROBIO, Inc.(NasdaqGS:AVRO) dropped from NASDAQ Composite Index	20/06	CI
Tectonic Therapeutic, Inc. completed the acquisition of AVROBIO, Inc. from a group of shareholders in a reverse merger transaction.	20/06	CI
Avrobio Insider Bought Shares Worth $971,493, According to a Recent SEC Filing	15/05	MT
AVROBIO, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	10/05	CI
AVROBIO INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of AVROBIO, Inc. - AVRO	10/05	BU
Tectonic Therapeutic Initiates Phase 1B Study for TX45 in Group 2 Pulmonary Hypertension in Patients with Preserved Ejection Fraction Heart Failure	27/03	AQ
North American Morning Briefing : Investors -2-	21/03	DJ
AVROBIO, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	15/03	CI
AVROBIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AVROBIO, Inc. - AVRO	14/02	BU
Shareholder Alert: Ademi LLP investigates whether AVROBIO, Inc. has obtained a Fair Price in its transaction with Tectonic	01/02	PR
AVRO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of AVROBIO, Inc. Is Fair to Shareholders	30/01	BU
Transcript : AVROBIO, Inc., Tectonic Therapeutic, Inc. - M&A Call	30/01
AVROBIO and Tectonic Therapeutic Announce Merger	30/01	BU
Tectonic Therapeutic, Inc. announced that it expects to receive $96.599856 million in funding from Tas Partners, LLC	30/01	CI
AVROBIO, Inc. entered into an agreement to acquire Tectonic Therapeutic, Inc.	30/01	CI
North American Morning Briefing : S&P 500 Eyes -2-	19/12	DJ
Mizuho Securities Cuts Avrobio Price Target to $2 From $5, Buy Rating Kept	18/12	MT
North American Morning Briefing : Caution Dominates Ahead of CPI Print	14/11	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Tectonic Therapeutic, Inc.

Equities

AVRO

US8789721086

All News

Filters